Monitoring of MTX therapy * currently not recommended by guidelines but may be a reasonable approach based on current literature.42, 102, 104
Liver biopsy: Not generally recommended except for persistent elevation of Liver function tests. * Consider Liver elastography as a monitoring tool especially for patients with risk factors such as obesity, NAFLD and alcohol consumption.